Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,930 | 799 | 83.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,792 | 2 | 13.1% |
| Consulting Fee | $600.00 | 1 | 2.8% |
| Education | $39.98 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $4,337 | 162 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,956 | 235 | $0 (2024) |
| ABBVIE INC. | $2,809 | 90 | $0 (2024) |
| RedHill Biopharma Inc. | $2,534 | 27 | $0 (2024) |
| FUJIFILM Medical Systems USA, Inc. | $1,292 | 1 | $0 (2017) |
| IRONWOOD PHARMACEUTICALS, INC | $940.60 | 49 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $611.53 | 29 | $0 (2022) |
| INTERCEPT PHARMACEUTICALS, INC. | $562.15 | 24 | $0 (2023) |
| Concordia Pharmaceuticals Inc. | $476.77 | 22 | $0 (2019) |
| Allergan Inc. | $456.79 | 21 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,158 | 109 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($629.86) |
| 2023 | $2,287 | 107 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($575.52) |
| 2022 | $2,013 | 104 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($754.01) |
| 2021 | $2,610 | 121 | Gilead Sciences, Inc. ($665.47) |
| 2020 | $3,514 | 79 | RedHill Biopharma Inc. ($2,185) |
| 2019 | $3,343 | 112 | Gilead Sciences, Inc. ($845.85) |
| 2018 | $2,276 | 91 | Gilead Sciences, Inc. ($678.02) |
| 2017 | $3,161 | 81 | FUJIFILM Medical Systems USA, Inc. ($1,292) |
All Payment Transactions
804 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.82 | General |
| 12/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: LIVER DISEASE | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $21.84 | General |
| Category: GI | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.19 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.46 | General |
| 11/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.41 | General |
| Category: GI | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.13 | General |
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $0.65 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.59 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 494 | 605 | $142,185 | $77,883 |
| 2022 | 10 | 567 | 657 | $192,954 | $98,066 |
| 2021 | 12 | 684 | 861 | $206,825 | $121,473 |
| 2020 | 7 | 531 | 697 | $169,124 | $82,753 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 224 | $32,908 | $17,398 | 52.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 45 | 45 | $26,864 | $15,520 | 57.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 118 | $24,773 | $13,267 | 53.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 36 | 36 | $18,638 | $10,164 | 54.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $14,224 | $8,028 | 56.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 16 | 16 | $10,372 | $6,740 | 65.0% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 18 | 20 | $3,244 | $1,948 | 60.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $6,000 | $1,876 | 31.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 31 | $3,192 | $1,521 | 47.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 31 | 35 | $1,970 | $1,419 | 72.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 65 | 67 | $41,577 | $24,877 | 59.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 131 | 154 | $41,397 | $17,987 | 43.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 148 | 205 | $39,756 | $15,807 | 39.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 38 | 38 | $19,155 | $11,071 | 57.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 23 | 23 | $15,691 | $10,172 | 64.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $11,400 | $6,920 | 60.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 16 | 16 | $10,178 | $5,009 | 49.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $7,750 | $2,844 | 36.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 57 | 65 | $4,160 | $2,636 | 63.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 14 | $1,890 | $742.75 | 39.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 240 | $48,300 | $29,084 | 60.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 71 | 73 | $42,676 | $27,851 | 65.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 173 | 272 | $44,179 | $23,276 | 52.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 23 | 24 | $16,448 | $11,094 | 67.4% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 37 | 37 | $18,720 | $10,963 | 58.6% |
About Dr. Anthony Ng, MD
Dr. Anthony Ng, MD is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649202367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Ng, MD has received a total of $21,362 in payments from pharmaceutical and medical device companies, with $2,158 received in 2024. These payments were reported across 804 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($17,930).
As a Medicare-enrolled provider, Ng has provided services to 2,276 Medicare beneficiaries, totaling 2,820 services with total Medicare billing of $380,174. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location New York, NY
- Active Since 07/06/2006
- Last Updated 11/17/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1649202367
Products in Payments
- XIFAXAN (Drug) $2,950
- Talicia (Drug) $1,916
- ESD - Core Endoscopy (Device) $1,292
- Creon (Drug) $1,067
- LINZESS (Drug) $946.14
- TRULANCE (Drug) $875.96
- Linzess (Drug) $589.46
- CREON (Drug) $577.68
- ZENPEP (Drug) $500.63
- VIBERZI (Drug) $463.74
- DIFICID (Drug) $426.25
- OCALIVA (Drug) $376.19
- Amitiza (Drug) $356.28
- PANCREAZE (Drug) $323.39
- Donnatal (Drug) $291.82
- Vemlidy (Drug) $275.62
- XELJANZ (Drug) $250.39
- MOTEGRITY (Drug) $238.28
- Epclusa (Drug) $224.99
- CONTRAVE (Drug) $190.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New York
Arthur Kornbluth, Md, MD
Gastroenterology — Payments: $2.4M
Dr. David Carr-Locke, Md Frcp Facg Masge, MD FRCP FACG MASGE
Gastroenterology — Payments: $2.3M
Jean-Frederic Colombel, M.d, M.D
Gastroenterology — Payments: $1.1M
Dr. Bruce Sands, Md, MD
Gastroenterology — Payments: $1.0M
Ellen Scherl, Md, MD
Gastroenterology — Payments: $880,329
Sonal Kumar, Md, MD
Gastroenterology — Payments: $769,554